| | | | | | | |
 | GILEAD SCIENCES, INC. | 0.82% | 3.06% | -13.29% | -11.17% | -1.59% | 78 912 |
| VERTEX PHARMACEUTICALS | 0.81% | 2.25% | 34.12% | 51.18% | 63.77% | 75 532 |
| REGENERON PHARMACEUTICALS, INC. | 0.77% | 2.46% | -0.44% | 3.41% | 112.50% | 67 214 |
 | WUXI APPTEC CO., LTD. | 0.24% | 0.68% | -20.10% | -31.94% | 135.45% | 40 830 |
| BIONTECH SE | 1.11% | -12.43% | -37.80% | -57.13% | --.--% | 38 968 |
 | GENMAB A/S | -3.16% | 3.09% | 0.23% | -10.22% | 106.66% | 23 726 |
 | ARGENX SE | 0.41% | 1.64% | 16.11% | 37.01% | 190.33% | 20 669 |
| BEIGENE, LTD. | -1.36% | -0.26% | -28.41% | -32.77% | 43.31% | 20 070 |
| NEUROCRINE BIOSCIENCES, INC. | 0.72% | 1.53% | 24.02% | 21.86% | 11.44% | 10 102 |
| SAREPTA THERAPEUTICS, INC. | -0.24% | 2.81% | 21.04% | 35.39% | -12.20% | 9 545 |
| KARUNA THERAPEUTICS, INC. | 6.17% | 97.65% | 111.77% | 159.47% | 1,138.48% | 9 277 |
| LEGEND BIOTECH CORPORATION | 1.93% | -5.76% | 0.79% | 17.13% | --.--% | 7 652 |
| EXELIXIS, INC. | 1.30% | -9.48% | 6.56% | 8.40% | -1.47% | 6 248 |
| ASCENDIS PHARMA A/S | 5.17% | 16.14% | -18.06% | -8.55% | -3.43% | 6 152 |
| HALOZYME THERAPEUTICS, INC. | -0.51% | -4.41% | 7.29% | 3.73% | 172.52% | 5 944 |
| | | | | | | |
| | Durchschnitt | 0.95% | 6.60% | 6.92% | 12.39% | 150.44% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 0.60% | 2.71% | 1.03% | 4.13% | 98.00% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
